FTC’s Crackdown on Pharma Mergers Reflects ‘Tougher’ M&A Environment Under Biden Administration: Lawyer
March 22, 2021
By: Eric Sagonowsky
FiercePharma
Axinn partner Jeny Maier was quoted in the FiercePharma article, "FTC's Crackdown on Pharma Mergers Reflects 'Tougher' M&A Environment Under Biden Administration: Lawyer." This quote also appeared in the April 21, 2021 Forbes article, “After Roaring in 2020, Biotech Stocks Now Weighed Down By Merger Scrutiny, FDA Approval Delays and Possible Drug Pricing Legislation.”
Click here to access the article.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
IPWatchdog Sixth Annual Live Conference
Speaking Engagement
Intellectual Property
ABA White Collar Crime Institute 2026
Speaking Engagement
GCR Live Cartels: 2026
Speaking Engagement
Antitrust
SCCE 14th Annual European Compliance & Ethics Institute
Speaking Engagement
Antitrust
Noerr Competition Day 2026
Speaking Engagement
Antitrust
Axinn Antitrust Insight: "New" HSR Form Remains in Effect For Now – Fifth Circuit Temporarily Freezes District Court Order that Vacated the New HSR Rule
Axinn Viewpoints
Antitrust
Consumer Brands CPG Legal Forum 2026
Speaking Engagement
NBA CLS 39th Annual Corporate Counsel Conference
Sponsorship
Antitrust
University of Pennsylvania Journal of Business Law Annual Symposium 2026
Speaking Engagement
Antitrust
Chambers Recognizes Axinn’s Antitrust Practice in 2026 Global Rankings — With New Recognition in Cartel Category
Awards & Recognitions
Antitrust
